GSK1059615

GSK1059615 · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK1059615, covering 2017-07-25 to 2017-07-25. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma [Phase 1]